Legend Biotech

Filed a patent for "bcma-targeted car-t cell therapy for multiple myeloma" on Wed, April 19, 2023

Filed a patent for "bcma-targeted car-t cell therapy for multiple myeloma" on Wed, May 24, 2023

Filed a patent for "fusion proteins and uses thereof" on Tue, September 26, 2023

Filed a patent for "multispecific antigen binding proteins and methods of use thereof" on Thu, February 23, 2023

Filed a patent for "compositions and methods for reducing graft rejection in allogeneic cell therapy" on Thu, May 18, 2023

Filed a patent for "bcma-targeted car-t cell therapy of multiple myeloma" on Wed, November 2, 2022

Filed a patent for "bcma-targeted car-t cell therapy for multiple myeloma" on Thu, September 7, 2023

Filed a patent for "compositions and methods for reducing host rejection of allogeneic cells using simian icp47 and variants thereof" on Thu, June 15, 2023

Filed a patent for "genetic engineering of gamma delta t cells for immunotherapy" on Thu, July 20, 2023

Filed a patent for "engineering gamma delta t cells with interleukin-36 for immunotherapy" on Thu, October 26, 2023

Filed a patent for "cd19 binding molecules and uses thereof" on Thu, June 22, 2023

Filed a patent for "cd22 binding molecules and uses thereof" on Thu, August 10, 2023

Filed a patent for "multispecific chimeric antigen receptors and uses thereof" on Thu, August 17, 2023

Filed a patent for "cd20 binding molecules and uses thereof" on Thu, August 31, 2023

Filed a patent for "t cell and antigen-presenting cell engagers and uses thereof" on Thu, February 8, 2024

Filed a patent for "methods and compositions for depleting natural killer cells and uses thereof in cellular therapies" on Thu, January 11, 2024

Filed a patent for "bcma-targeted car-t cell therapy for multiple myeloma" on Thu, January 4, 2024

Filed a patent for "engineered cells and uses thereof" on Thu, February 15, 2024

Filed a patent for "methods of minimizing neurotoxicity associated with chimeric antigen receptor (car) t cell therapy" on Thu, March 2, 2023

Filed a patent for "single domain antibodies and chimeric antigen receptors targeting bcma and methods of use thereof" on Thu, February 23, 2023

Filed a patent for "claudin18.2 binding moieties and uses thereof" on Thu, June 22, 2023

Filed a patent for "antibodies and chimeric antigen receptors targeting glypican-3 (gpc3) and methods of use thereof" on Thu, March 23, 2023

Filed a patent for "glypican-2-binding moieties, chimeric antigen receptors and uses thereof" on Thu, May 4, 2023